Confirmation of administrative claims-identified opportunistic infections and other serious potential adverse events associated with tumor necrosis factor alpha antagonists and disease-modifying antirheumatic drugs.

Academic Article


  • Adult, Antibodies, Monoclonal, Antirheumatic Agents, Arthritis, Rheumatoid, Crohn Disease, Databases, Factual, Etanercept, Female, Humans, Immunoglobulin G, Incidence, Infliximab, Insurance, Health, Male, Middle Aged, Opportunistic Infections, Predictive Value of Tests, Receptors, Tumor Necrosis Factor, Tumor Necrosis Factor-alpha
  • Digital Object Identifier (doi)

    Pubmed Id

  • 17699448
  • Author List

  • Curtis JR; Martin C; Saag KG; Patkar NM; Kramer J; Shatin D; Allison J; Braun MM
  • Start Page

  • 343
  • End Page

  • 346
  • Volume

  • 57
  • Issue

  • 2